At 24 weeks the combination with Tirz using the 15 plus 9 titration reached 25 percent. That stands out. The top dose of 15 plus 9 reached 29 percent by week 31. This pairing beats Reta and produces fewer sides.
They presented it in Milan today. The Elora plus Tirz study in people with type 2 diabetes is also scheduled for later. I expect it will turn out to be fairly unremarkable since the outcomes will likely be comparable, though possibly with modestly lower weight loss in that group. This is only my speculation though.